Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer

Fiorella Magani1,2, Eric R Bray3, Maria J Martinez2

  • 1Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, USA.

Insights

Researchers discovered a novel gene network driving prostate cancer (PC) progression and therapeutic resistance. This finding offers new targets for improving PC prognosis and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Systems Biology

Background:

  • Identifying key pathways is crucial for prostate cancer (PC) prognosis and therapy.
  • Therapeutic resistance in PC is often driven by constitutively active androgen receptor (AR) splice variants.
  • Novel strategies are needed to uncover genes involved in AR variant-driven resistance.

Purpose of the Study:

  • To develop a systems-level gene discovery strategy to identify critical pathways in PC.
  • To uncover AR variant-driven genes that contribute to PC progression and therapeutic resistance.
  • To identify potential prognostic and therapeutic targets for prostate cancer.

Main Methods:

  • Meta-analysis of human prostate samples using weighted gene co-expression network analysis.
  • Experimental AR variant transcriptome analyses.
  • High-throughput synthetic genetic array screen in *Schizosaccharomyces pombe* to identify functional interactions with AR variants.

Main Results:

  • Identified an AR variant-driven gene module upregulated during PC progression.
  • Discovered seven AR variant-regulated genes that enhance AR activity and promote cancer progression.
  • These seven genes predicted poor disease-free survival in independent PC patient cohorts.
  • Pharmacologic inhibition of interacting genes synergistically decreased PC cell proliferation.

Conclusions:

  • A novel, unbiased gene discovery strategy identified a clinically relevant gene hub in PC.
  • This gene hub is oncogenic, has strong prognostic potential, and offers therapeutic opportunities.
  • Targeting this AR variant-regulated gene network may overcome therapeutic resistance in prostate cancer.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Protein Networks02:26

Protein Networks

2.9K
Network Covalent Solids02:18

Network Covalent Solids

Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
Therapeutic Communication01:30

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.5K